Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Nikunj Satani
Affiliation
University of Texas MD Anderson Cancer Center
ORCID
Career Start Year
2011
Papers
27
H Index
15
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36798479
Comparative Pharmacology of a Bis-Pivaloyloxymethyl Phosphonate Prodrug Inhibitor of Enolase after Oral and Parenteral Administration.
ACS Pharmacol Transl Sci
2023
36251833
Prodrugs of a 1-Hydroxy-2-oxopiperidin-3-yl Phosphonate Enolase Inhibitor for the Treatment of <i>ENO1</i>-Deleted Cancers.
J Med Chem
2022
36277912
Peripheral blood monocytes as a therapeutic target for marrow stromal cells in stroke patients.
Front Neurol
2022
33123754
Aurora kinase inhibition sensitizes melanoma cells to T-cell-mediated cytotoxicity.
Cancer Immunol Immunother
2021
33616305
A meta-analysis of the global impact of the COVID-19 pandemic on stroke care & the Houston Experience.
Ann Clin Transl Neurol
2021
33807314
Mesenchymal Stem Cell Derived Extracellular Vesicles for Repairing the Neurovascular Unit after Ischemic Stroke.
Cells
2021
34244484
Homozygous MTAP deletion in primary human glioblastoma is not associated with elevation of methylthioadenosine.
Nat Commun
2021
33959001
A Combination of Atorvastatin and Aspirin Enhances the Pro-Regenerative Interactions of Marrow Stromal Cells and Stroke-Derived Monocytes <i>In Vitro</i>.
Front Pharmacol
2021
33340032
Author Correction: An enolase inhibitor for the targeted treatment of ENO1-deleted cancers.
Nat Metab
2021
32802081
Medications for Hypertension Change the Secretome Profile from Marrow Stromal Cells and Peripheral Blood Monocytes.
Stem Cells Int
2020
33230295
An enolase inhibitor for the targeted treatment of ENO1-deleted cancers.
Nat Metab
2020
30890995
Ongoing Secondary Degeneration of the Limbic System in Patients With Ischemic Stroke: A Longitudinal MRI Study.
Front Neurol
2019
31324042
The 3<i>S</i> Enantiomer Drives Enolase Inhibitory Activity in SF2312 and Its Analogues.
Molecules
2019
31220426
Aspirin in stroke patients modifies the immunomodulatory interactions of marrow stromal cells and monocytes.
Brain Res
2019
31068894
World-Wide Efficacy of Bone Marrow Derived Mesenchymal Stromal Cells in Preclinical Ischemic Stroke Models: Systematic Review and Meta-Analysis.
Front Neurol
2019
28836238
Protective Effects of Autologous Bone Marrow Mononuclear Cells After Administering t-PA in an Embolic Stroke Model.
Transl Stroke Res
2018
29267866
The Effect of Topoisomerase I Inhibitors on the Efficacy of T-Cell-Based Cancer Immunotherapy.
J Natl Cancer Inst
2018
29316430
Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment.
Cancer Cell
2018
27856228
Mesenchymal stromal cell secretomes are modulated by suspension time, delivery vehicle, passage through catheter, and exposure to adjuvants.
Cytotherapy
2017
28099419
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreatic cancer.
Nature
2017
28878208
HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genes.
Nat Commun
2017
28697342
Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment.
Cancer Cell
2017
27485235
Is Immunomodulation a Principal Mechanism Underlying How Cell-Based Therapies Enhance Stroke Recovery?
Neurotherapeutics
2016
27723749
SF2312 is a natural phosphonate inhibitor of enolase.
Nat Chem Biol
2016
28030597
ENOblock Does Not Inhibit the Activity of the Glycolytic Enzyme Enolase.
PLoS One
2016
27403167
Cryopreservation of Bone Marrow Mononuclear Cells Alters Their Viability and Subpopulation Composition but Not Their Treatment Effects in a Rodent Stroke Model.
Stem Cells Int
2016
20889378
The intricate mechanisms of neurodegeneration in prion diseases.
Trends Mol Med
2011
1 - 27 of 27
Column Actions
Search
Recommended Authors
Zhiyuan Mao
College of Life Science and Engineering, Southwest Jiaotong University
Career Start Year
2015
Number of shared co-authors
0
Kimberly E Hawkins
College of Medicine, University of Florida
Career Start Year
2013
Number of shared co-authors
0
Nayeon Lee
Seoul National University
Career Start Year
2012
Number of shared co-authors
0
Nathan L Weinbren
Boston Children's Hospital
Career Start Year
2010
Number of shared co-authors
0
Kyle B Walsh
University of Cincinnati
Career Start Year
2009
Number of shared co-authors
0
Maryam Rahman
University of Florida
Career Start Year
2008
Number of shared co-authors
0
Matthew B Bevers
Brigham and Women's Hospital
Career Start Year
2008
Number of shared co-authors
0
Stefania Mondello
University of Messina
Career Start Year
2007
Number of shared co-authors
0
Akshitkumar M Mistry
University of Louisville
Career Start Year
2006
Number of shared co-authors
0
Hyun-Ji Cho
Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea
Career Start Year
2004
Number of shared co-authors
0
Qi Fang
The First Affiliated Hospital of Soochow University
Career Start Year
2002
Number of shared co-authors
0
Kyeung Min Joo
Cancer Stem Cell Research Center, Samsung Biomedical Research Institute
Career Start Year
2002
Number of shared co-authors
2
Khalid A Hanafy
Charles E. Schmidt College of Medicine, Florida Atlantic University
Career Start Year
2001
Number of shared co-authors
0
Bryan Yoo
David Geffen School of Medicine, University of California Los Angeles
Career Start Year
2000
Number of shared co-authors
0
Xabier Urra
Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS)
Career Start Year
2000
Number of shared co-authors
0
Gilberto Ka Kit Leung
The University of Hong Kong
Career Start Year
1999
Number of shared co-authors
2
May Nour
University of California Los Angeles
Career Start Year
1999
Number of shared co-authors
1
Bonghee Lee
Lee Gil Ya Cancer and Diabetes Institute, Gachon University
Career Start Year
1997
Number of shared co-authors
0
Clifton L Dalgard
Uniformed Services University of the Health Sciences
Career Start Year
1997
Number of shared co-authors
1
Nam D Tran
Moffitt Cancer Center
Career Start Year
1995
Number of shared co-authors
0
Katerina Akassoglou
Gladstone Institute for Neurological Disease San Francisco
Career Start Year
1995
Number of shared co-authors
0
William T Kimberly
Massachusetts General Hospital, Harvard Medical School
Career Start Year
1994
Number of shared co-authors
0
Ling-Yuan Kong
The University of Texas MD Anderson Cancer Center
Career Start Year
1994
Number of shared co-authors
7
Seung Hoon Lee
Korea University College of Medicine, Korea University Ansan Hospital
Career Start Year
1993
Number of shared co-authors
2
Bj??rn Scheffler
German Cancer Research Center (DKFZ)
Career Start Year
1992
Number of shared co-authors
0
Stanley Thomas Carmichael
David Geffen School of Medicine at University of California-Los Angeles
Career Start Year
1991
Number of shared co-authors
1
Daniel T Laskowitz
Duke University
Career Start Year
1991
Number of shared co-authors
1
Christian Dohmen
University Hospital Cologne
Career Start Year
1990
Number of shared co-authors
0
Bob S Carter
Massachusetts General Hospital and Harvard Medical School
Career Start Year
1990
Number of shared co-authors
2
Susan C Fagan
Charlie Norwood Veterans Affairs Medical Center
Career Start Year
1984
Number of shared co-authors
0
row(s) 1 - 30 of 30
Collaborators
Sean I Savitz
University of Texas Health Science Center at Houston
Co-authored papers
12
Roel G W Verhaak
Yale School of Medicine
Co-authored papers
3
Timothy P Heffernan
Co-authored papers
3
Gaetano Finocchiaro
IRCCS San Raffaele Scientific Institute
Co-authored papers
2
Waldemar Priebe
The University of Texas MD Anderson Cancer Center
Co-authored papers
2
Hoon Kim
Co-authored papers
2
Amy B Heimberger
Northwestern University Feinberg School of Medicine
Co-authored papers
2
Qianghu Wang
Center for Global Health, School of Public Health, Nanjing Medical University
Co-authored papers
2
Lisa Scarpace
Co-authored papers
2
Jianhua Hu
Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences
Co-authored papers
2
Mitchel S Berger
University of California san francisco
Co-authored papers
2
Erik P Sulman
NYU Grossman School of Medicine
Co-authored papers
2
Massimo Squatrito
Seve Ballesteros Foundation Brain Tumor group
Co-authored papers
2
Hee Jin Cho
Touro College of Osteopathic Medicine
Co-authored papers
2
Steven W Millward
University of Texas MD Anderson Cancer Center
Co-authored papers
2
Baoli Hu
Co-authored papers
2
Do-Hyun Nam
Samsung Medical Center, Sungkyunkwan University School
Co-authored papers
2
Yaoqi Alan Wang
The University of Texas MD Anderson Cancer Center
Co-authored papers
2
Siyuan Zheng
Greehey Children's Cancer Research Institute
Co-authored papers
2
Tom Mikkelsen
Ontario Brain Institute
Co-authored papers
2
Joanna J Phillips
University of California san francisco
Co-authored papers
2
Sujan T Reddy
University of Texas Health Science Center at Houston
Co-authored papers
1
Tzu-Ching Wu
12339University of Texas McGovern Medical School
Co-authored papers
1
Amirali Tahanan
The University of Texas Health Science Center at Houston
Co-authored papers
1
Anirban Maitra
The University of Texas MD Anderson Cancer Center
Co-authored papers
1
John F de Groot
Co-authored papers
1
Sori Kim
School of Public Health, The University of Texas Health Science Center at Houston
Co-authored papers
1
Jason T Huse
Co-authored papers
1
Suja S Rajan
UTHealth School of Public Health
Co-authored papers
1
Luyao Chen
University of Texas Health Science Center at Houston
Co-authored papers
1
1 - 30